Aardvark Therapeutics
AARD----
Aardvark Therapeutics (AARD)
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathwa...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Aardvark Therapeutics Analyst Rating
View MoreForecast & Rating
Jul 23, 2026Price forecast
$14.50129.43%
Forecast & RatingBuy
12analysts
- Strong buy50.00%
- Buy0.00%
- Hold33.33%
- Sell8.33%
- Strong sell8.33%
News
- Market Beat · Jul 16 at 05:20 AM
Aardvark Therapeutics, Inc. (NASDAQ:AARD) Short Interest Update
- benzinga_article · Jul 10 at 04:05 PM
12 Health Care Stocks Moving In Friday's After-Market Session
- PUBT · Jun 29 at 03:06 PM
Aardvark Therapeutics announces annual shareholder meeting
- PR Newswire · May 28 at 08:00 AM
Aardvark Therapeutics (AARD) Faces Investor Scrutiny Amid 56% Drop On Clinical Pause For Lead Drug Candidate- HBSS
- prnewswire · May 21 at 05:42 PM
18:40 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aardvark Therapeutics, Inc. - AARD
- MorningStar · May 18 at 05:19 AM
North American Morning Briefing: Stock Futures Slip Amid Mideast, Inflation Pessimism
